ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0877

Loss of Transient Receptor Potential Channel 1 (TRPC1) Links Regulation of Intracellular Calcium to Cellular Senescence and Leads to Development of Osteoarthritis

Meike Sambale1, starlee lively2, Osvaldo Espin-Garcia2, Pratibha Potla2, Chiara Pastrello3, Alexandra Schaefer1, Jessica Bertrand4, Mohit Kapoor5, Thomas Pap1 and Joanna Sherwood1, 1University Hospital Münster, Münster, Germany, 2University Health Network, Toronto, ON, Canada, 3Osteoarthritis Research Program, Division of Orthopaedic Surgery, Schroeder Arthritis Institute and Data Science Discovery Centre for Chronic diseases, Krembil Research Institute, Toronto, ON, Canada, 4Department of Orthopaedic Surgery, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany, 5Division of Orthopaedics, Osteoarthritis Research Program, Schroeder Arthritis Institute, and Krembil Research Institute, University Health Network, Toronto, ON, Canada

Meeting: ACR Convergence 2023

Keywords: Animal Model, cartilage, Cartilage Mechano biology, chondrocyte, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0859–0885) Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Transient receptor potential channel 1 (TRPC1) is a widely expressed mechanosensitive ion channel located within the endoplasmic reticulum membrane. It is crucial for the refilling of depleted internal calcium stores as part of calcium-dependent signaling. Considering the impact of calcium signaling regulation on both homeostatic and inflammatory signaling in chondrocytes, we aimed to examine the role of TRPC1 within cartilage homeostasis and osteoarthritis by monitoring expression during human and murine osteoarthritis (OA) and by assessing the impact of TRPC1 deficiency on OA development and chondrocyte phenotypic stability.

Methods: 10-week old male WT and Trpc1-/- mice were subjected to destabilization of the medial meniscus (DMM) and were analyzed by microCT, RNA sequencing, histology and immunofluorescence staining at either 2 weeks or 8 weeks post-surgery for OA severity, TRPC1 expression and phenotypic marker expression. TRPC1 protein expression was evaluated in human OA cartilage samples by immunohistochemistry. In vitro, the phenotype of knee articular chondrocytes obtained from 4 day old mice was compared by QPCR, Western blot, SA-b-Gal staining and immunofluorescence. Intracellular calcium mobilization was measured by fluo-4 calcium influx assay.

Results: TRPC1 was found to be depleted from chondrocytes during both human and murine OA development. Trpc1-/- mice subjected to DMM developed a more severe OA-like phenotype than wild type (WT) controls. Analysis 2 weeks post-DMM revealed an increased rate of chondrocyte survival in Trpc1-/- cartilage, with remaining cells expressing less SOX9 and increased levels of MMP13 and the senescence marker p16INK4a. RNA sequencing followed by GO analysis of articular cartilage from Trpc1-/- and WT mice identified a set of differentially expressed genes related to cell number, apoptosis and extracellular matrix organization biological processes.In vitro, stimulation of WT chondrocytes with bFGF, ionomycin or thapsigargin all led to an increase in intracellular calcium, however these effects were significantly reduced in Trpc1-/-chondrocytes. Although Trpc1-/- chondrocytes expressed similar levels of chondrocyte differentiation markers at basal level as WT controls, Trpc1-/- chondrocytes lost expression of type II collagen and increased type I collagen expression significantly faster than WT during serial passage. Replicative senescence and p16INK4a expression was found to be significantly higher in Trpc1-/-, both during passage and following IL1 stimulation.

Conclusion: Trpc1-/- chondrocytes were less able to maintain a stable chondrocyte phenotype in vitro than WT, indicating that TRPC1 activity is required for chondrocyte phenotypic stability. TRPC1 loss was associated with early stages of OA development, while Trpc1-/- mice developed a more severe OA-like phenotype following DMM surgery. Both in vivo following DMM, andin vitro during passage and following IL1 stimulation, Trpc1-/- chondrocytes demonstrated an increased susceptibility to cellular senescence. These findings suggest that TRPC1 is a protective factor required for cartilage homeostasis during conditions of physiological challenge.


Disclosures: M. Sambale: None; s. lively: None; O. Espin-Garcia: None; P. Potla: None; C. Pastrello: None; A. Schaefer: None; J. Bertrand: None; M. Kapoor: None; T. Pap: AbbVie/Abbott, 2, Galapagos, 5, UCB, 2; J. Sherwood: None.

To cite this abstract in AMA style:

Sambale M, lively s, Espin-Garcia O, Potla P, Pastrello C, Schaefer A, Bertrand J, Kapoor M, Pap T, Sherwood J. Loss of Transient Receptor Potential Channel 1 (TRPC1) Links Regulation of Intracellular Calcium to Cellular Senescence and Leads to Development of Osteoarthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/loss-of-transient-receptor-potential-channel-1-trpc1-links-regulation-of-intracellular-calcium-to-cellular-senescence-and-leads-to-development-of-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/loss-of-transient-receptor-potential-channel-1-trpc1-links-regulation-of-intracellular-calcium-to-cellular-senescence-and-leads-to-development-of-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology